Stock listing
TSXV:ROMJ Rubicon Organics, Inc. Stock
Home listing (TSXV) of Rubicon Organics, Inc.
Follow Rubicon Organics, Inc. into a list and get an email when it puts out news.
Share price · TSXV:ROMJ
$0.35 CAD -0.01 (-1.4%)
Close on Nov 20, 2026
- Day range
- $0.35 – $0.35 CADNov 20, 2026
- Volume
- 1,017 sharesNov 20, 2026
- Market cap
- $25.99M CADAt the close on Nov 20, 2026 · price × 74.25M shares outstanding
- 52-week range
- $0.345 – $0.60 CADLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $45,404 CADMedian day 45,900 shares · 1 day with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| TSXV:ROMJ · Home | $0.35 CAD | -0.005 (-1.4%) | 1,017 | $0.35 | $0.35 | $0.35 | $0.355 | Close on Nov 20, 2026 |
| OTC:ROMJF | $0.241 USD | +0.007 (+3.0%) | 126 | $0.241 | $0.241 | $0.241 | $0.234 | Close on Nov 20, 2026 |
| Frankfurt:R07 | €0.202 EUR | -0.012 (-5.6%) | — | €0.202 | €0.202 | €0.202 | €0.214 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TSXV:ROMJ · CAD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.35 | -0.005 | -1.4% | $0.35 | $0.35 | $0.35 | 1,017 | |
| $0.355 | -0.015 | -4.1% | $0.36 | $0.36 | $0.345 | 115,529 | |
| $0.37 | +0.005 | +1.4% | $0.35 | $0.37 | $0.35 | 101,500 | |
| $0.365 | -0.06 | -14.1% | $0.35 | $0.37 | $0.35 | 293,069 | |
| $0.425 | +0.025 | +6.2% | $0.40 | $0.44 | $0.40 | 55,995 | |
| $0.40 | 0.00 | 0.0% | $0.40 | $0.40 | $0.40 | 0 | |
| $0.40 | -0.015 | -3.6% | $0.41 | $0.41 | $0.395 | 373,000 | |
| $0.415 | -0.005 | -1.2% | $0.42 | $0.42 | $0.39 | 166,200 | |
| $0.42 | -0.01 | -2.3% | $0.425 | $0.43 | $0.41 | 24,201 | |
| $0.43 | +0.01 | +2.4% | $0.43 | $0.435 | $0.43 | 5,636 | |
| $0.42 | +0.005 | +1.2% | $0.42 | $0.42 | $0.385 | 67,925 | |
| $0.415 | +0.04 | +10.7% | $0.375 | $0.415 | $0.37 | 85,000 | |
| $0.375 | +0.015 | +4.2% | $0.36 | $0.385 | $0.345 | 275,130 | |
| $0.36 | -0.015 | -4.0% | $0.375 | $0.375 | $0.345 | 638,162 | |
| $0.375 | 0.00 | 0.0% | $0.38 | $0.38 | $0.36 | 439,702 | |
| $0.375 | -0.01 | -2.6% | $0.385 | $0.385 | $0.37 | 130,025 | |
| $0.385 | -0.015 | -3.8% | $0.40 | $0.40 | $0.38 | 145,879 | |
| $0.40 | -0.015 | -3.6% | $0.41 | $0.415 | $0.37 | 169,903 | |
| $0.415 | -0.01 | -2.4% | $0.425 | $0.425 | $0.415 | 5,301 | |
| $0.425 | -0.005 | -1.2% | $0.43 | $0.43 | $0.425 | 82,666 | |
| $0.43 | -0.01 | -2.3% | $0.44 | $0.44 | $0.43 | 121,600 | |
| $0.44 | 0.00 | 0.0% | $0.44 | $0.44 | $0.44 | 89,500 | |
| $0.44 | 0.00 | 0.0% | $0.44 | $0.44 | $0.44 | 44,700 | |
| $0.44 | 0.00 | 0.0% | $0.44 | $0.45 | $0.44 | 43,400 | |
| $0.44 | 0.00 | 0.0% | $0.44 | $0.44 | $0.44 | 1,000 | |
| $0.44 | 0.00 | 0.0% | $0.44 | $0.45 | $0.44 | 8,000 | |
| $0.44 | -0.01 | -2.2% | $0.45 | $0.45 | $0.43 | 41,900 | |
| $0.45 | 0.00 | 0.0% | $0.45 | $0.45 | $0.44 | 27,100 | |
| $0.45 | +0.01 | +2.3% | $0.44 | $0.46 | $0.43 | 122,100 | |
| $0.44 | -0.01 | -2.2% | $0.45 | $0.45 | $0.44 | 15,700 | |
| $0.45 | 0.00 | 0.0% | $0.45 | $0.45 | $0.45 | 48,400 | |
| $0.45 | -0.01 | -2.2% | $0.47 | $0.47 | $0.44 | 73,200 | |
| $0.46 | 0.00 | 0.0% | $0.46 | $0.46 | $0.44 | 39,100 | |
| $0.46 | 0.00 | 0.0% | $0.46 | $0.46 | $0.46 | 1,000 | |
| $0.46 | -0.03 | -6.1% | $0.46 | $0.46 | $0.46 | 22,000 | |
| $0.49 | +0.01 | +2.1% | $0.48 | $0.49 | $0.47 | 32,600 | |
| $0.48 | +0.03 | +6.7% | $0.48 | $0.48 | $0.48 | 1,000 | |
| $0.45 | -0.02 | -4.3% | $0.47 | $0.47 | $0.44 | 140,100 | |
| $0.47 | 0.00 | 0.0% | $0.47 | $0.47 | $0.47 | 14,000 | |
| $0.47 | 0.00 | 0.0% | $0.47 | $0.47 | $0.47 | 2,500 | |
| $0.47 | -0.01 | -2.1% | $0.48 | $0.48 | $0.47 | 8,500 | |
| $0.48 | 0.00 | 0.0% | $0.48 | $0.48 | $0.48 | 6,000 | |
| $0.48 | 0.00 | 0.0% | $0.48 | $0.48 | $0.48 | 700 | |
| $0.48 | +0.02 | +4.3% | $0.46 | $0.48 | $0.46 | 40,000 | |
| $0.46 | 0.00 | 0.0% | $0.46 | $0.46 | $0.46 | 1,000 | |
| $0.46 | 0.00 | 0.0% | $0.46 | $0.46 | $0.44 | 6,700 | |
| $0.46 | -0.01 | -2.1% | $0.46 | $0.46 | $0.45 | 218,800 | |
| $0.47 | -0.01 | -2.1% | $0.47 | $0.47 | $0.46 | 10,500 | |
| $0.48 | -0.01 | -2.0% | $0.48 | $0.49 | $0.47 | 6,500 | |
| $0.49 | +0.02 | +4.3% | $0.48 | $0.49 | $0.47 | 12,300 | |
| $0.47 | 0.00 | 0.0% | $0.47 | $0.47 | $0.47 | 1,500 | |
| $0.47 | -0.01 | -2.1% | $0.49 | $0.51 | $0.47 | 47,100 | |
| $0.48 | -0.03 | -5.9% | $0.49 | $0.49 | $0.47 | 178,500 | |
| $0.51 | +0.01 | +2.0% | $0.51 | $0.51 | $0.51 | 19,100 | |
| $0.50 | -0.03 | -5.7% | $0.54 | $0.54 | $0.50 | 240,300 | |
| $0.53 | -0.02 | -3.6% | $0.55 | $0.55 | $0.51 | 147,000 | |
| $0.55 | -0.04 | -6.8% | $0.59 | $0.59 | $0.55 | 32,400 | |
| $0.59 | +0.01 | +1.7% | $0.57 | $0.59 | $0.57 | 33,000 | |
| $0.58 | -0.01 | -1.7% | $0.57 | $0.58 | $0.55 | 111,500 | |
| $0.59 | +0.01 | +1.7% | $0.56 | $0.60 | $0.56 | 114,400 | |
| $0.58 | +0.02 | +3.6% | $0.57 | $0.59 | $0.56 | 111,000 | |
| $0.56 | +0.01 | +1.8% | $0.55 | $0.57 | $0.54 | 141,200 | |
| $0.55 | +0.01 | +1.9% | $0.53 | $0.55 | $0.50 | 339,100 | |
| $0.54 | +0.05 | +10.2% | $0.50 | $0.60 | $0.49 | 621,700 |
- Ticker
- TSXV:ROMJ
- Asset type
- Stock
- Sector
- Consumer goods
- Industry
- Tobacco & cannabis
- Exchange
- TSXV
- Currency
- CAD
What changed lately
Latest news release · Nov 16, 2026
Rubicon Organics Reports Q3 2026 Financial Results
Latest earnings call · Nov 16, 2026
Rubicon Organics (TSXV:ROMJ) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Nov 16, 2026
Investor Presentation (November 2026)
Investor deck · 17 slides
Latest news
Rubicon Organics Reports Q3 2026 Financial Results
Nov 16, 2026
Closed $0.365 (-14.1%) on Nov 16, 2026
Rubicon Organics Announces Dedicated Genetics Facility
Nov 9, 2026
Closed $0.42 (-2.3%) on Nov 9, 2026
Rubicon Organics to Report Q3 2026 Results
Nov 2, 2026
Closed $0.36 (-4.0%) on Nov 2, 2026
Rubicon Organics Announces $3 Million Strategic Private Placement to Expand Pacifica Cultivation Capacity
Oct 19, 2026
Closed $0.44 (0.0%) on Oct 19, 2026
Rubicon Organics Announces Annual General Meeting Results
Sep 24, 2026
Closed $0.47 (0.0%) on Sep 25, 2026
Rubicon Organics Expands 1964 Supply Co.™ U.K. Portfolio with Full Spectrum Vapes
Sep 18, 2026
Closed $0.48 (+4.3%) on Sep 18, 2026
Rubicon Organics to Present at Upcoming Investor and Industry Conferences
Sep 16, 2026
Closed $0.46 (0.0%) on Sep 16, 2026
Rubicon Organics Announces Details of Annual General Meeting
Sep 3, 2026
Closed $0.51 (+2.0%) on Sep 3, 2026
Rubicon Organics Reports Q2 2026 Financial Results
Aug 12, 2026
Closed $0.50 (+2.0%) on Aug 12, 2026
Rubicon Organics to Report Q2 2026 Results
Jul 28, 2026
Closed $0.46 (+2.2%) on Jul 28, 2026
Rubicon Organics, Inc. on 6ix
- Sector
- Consumer goods
- Industry
- Tobacco & cannabis
- News releases
- 24 in the last 12 months · 79 in all · newest Nov 16, 2026 · oldest 2018
- Calls
- 18 calls with a replay · 18 with a transcript · latest Nov 16, 2026
- Decks
- 35 decks · latest Nov 16, 2026
Where Rubicon Organics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| TSXV:ROMJ · Home listing · This page | TSXV | Canada | CAD |
| OTC:ROMJF | OTC | United States | USD |
| Cboe Canada:ROMJ | Cboe Canada | Canada | CAD |
| LS Exchange:A2N7HE | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2N7HE | Lang & Schwarz | Germany | EUR |
| Frankfurt:R07 | Frankfurt | Germany | EUR |
| Dusseldorf:R07 | Dusseldorf | Germany | EUR |
| Stuttgart:R07 | Stuttgart | Germany | EUR |
Cash and shares
Nov 2026 deck · Rubicon Organics — Investor Presentation (November 2026)
- Fully diluted
- 87,992,622
Valuation
EV/sales 0.5× against a median of 0.8×: 4th lowest of 10 Tobacco & cannabis companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $32.90M CAD
- P/E
- Loss
- EV/sales
- 0.5×
- EV/EBITDA
- 10.3×
- Price/book
- 0.6×
- Gross margin
- 36.0%
- Operating margin
- −1.4%
- Net margin
- −2.7%
- Debt to equity
- 0.2×
- Beta vs S&P/TSX Composite
- 0.56
Tobacco & cannabis: the 10 companies nearest in size, of 97 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Rubicon Organics, Inc. · TSXV:ROMJ | US$18.12M | US$22.94M | n/a | 0.5× | 10.3× | 0.6× | −2.7% | 0.2× | 0.56 |
| Little Green Pharma Ltd. · ASX:LGP | US$36.17M | US$38.34M | n/a | 1.4× | 31.3× | 0.7× | −3.3% | 0.1× | n/a |
| iAnthus Capital Holdings, Inc. · CSE:IAN | US$24.32M | US$226.4M | n/a | 1.6× | n/a | n/a | −39.3% | n/a | 0.00 |
| Charlie's Holdings, Inc. · OTC:CHUC | US$23.85M | US$23.49M | n/a | 1.0× | n/a | 17.1× | −19.4% | 0.0× | 0.22 |
| Vext Science, Inc. · CSE:VEXT | US$22.68M | US$40.58M | n/a | 0.8× | 3.3× | 0.4× | −28.4% | 0.4× | 0.10 |
| Planet 13 Holdings Inc · CSE:PLTH | US$22.21M | US$27.45M | n/a | 0.3× | n/a | 0.7× | −26.7% | 0.3× | 0.76 |
| RYTHM, Inc. · NASDAQ:RYM | US$20.88M | US$53.26M | 3.0× | 0.8× | 13,314× | 0.5× | 9.8% | 1.9× | 1.80 |
| MariMed Inc. · CSE:MRMD | US$19.82M | US$91.35M | n/a | 0.6× | 15.2× | 0.5× | −9.3% | 2.0× | 0.55 |
| MediPharm Labs Corp. · TSX:LABS | US$17.87M | US$11.05M | n/a | 0.4× | n/a | 0.7× | −6.5% | 0.0× | 0.87 |
| Kombinat Konopny SA · NEWCONNECT:KMB | US$11.75M | US$12.82M | n/a | n/a | n/a | 8.6× | n/a | 0.9× | n/a |
| 1CM Inc. · CSE:EPIC | US$10.67M | US$3.97M | 3.2× | 0.1× | 1.9× | 0.5× | 6.3% | 0.0× | -0.44 |
| Median of the others | US$21.55M | US$32.90M | 3.1× | 0.8× | 15.2× | 0.7× | −9.3% | 0.3× | 0.39 |
Forecasts
Analysts' consensus from EODHD, read Nov 18, 2026. Not 6ix's view and not investment advice.
- Price target
- 1.15 CAD · Analysts' mean
- EPS, year to Dec 2026
- -0.027 · 3 analysts
- Revenue, year to Dec 2026
- 69.03M · 3 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Margaret Brodie; | Chief Executive Officer |
| Glen Ibbott | Chief Financial Officer |
| Melanie Ramsey | Chief Operating Officer |
| Bob Hill | VP, Strategic Finance |
| Mathieu Aubin | VP, Marketing & New Business |
| Monika Mascitti | VP, People & Culture |
| Tyler Perkins | VP, Operations |
Board
| Director | Role |
|---|---|
| Doris Bitz | Chair |
| Jesse McConnell | Director |
| John Pigott | Independent Director |
| Margaret Brodie; | Chief Executive Officer |
| Michael Detlefsen | Independent Director |
Events
Calls
| Call | When | Status |
|---|---|---|
| Rubicon Organics (TSXV:ROMJ) Q3 2026 Earnings Call | Mon, Nov 16, 2026 · 9:00 AM ET | Replay |
| Rubicon Organics (TSXV:ROMJ) Q2 2026 Earnings Call | Wed, Aug 12, 2026 · 10:00 AM ET | Replay |
| Rubicon Organics (TSXV:ROMJ) Q1 2026 Earnings Call | Thu, May 14, 2026 · 10:00 AM ET | Replay |
| Rubicon Organics (TSXV:ROMJ) Q4 2025 Earnings Call | Tue, Mar 24, 2026 · 10:00 AM ET | Replay |
| Rubicon Organics (TSXV:ROMJ) Q3 2025 Earnings Call | Thu, Nov 13, 2025 · 10:00 AM ET | Replay |
| Rubicon Organics (TSXV:ROMJ) Q2 2025 Earnings Call | Mon, Aug 18, 2025 · 10:00 AM ET | Replay |
| Rubicon Organics (TSXV:ROMJ) Q1 2025 Earnings Call | Wed, May 28, 2025 · 10:00 AM ET | Replay |
| Rubicon Organics (TSXV:ROMJ) Q4 2024 Earnings Call | Wed, Apr 02, 2025 · 10:00 AM ET | Replay |
| Rubicon Organics (TSXV:ROMJ) Q2 2024 Earnings Call | Thu, Aug 15, 2024 · 10:00 AM ET | Replay |
| Rubicon Organics (TSXV:ROMJ) Q1 2024 Earnings Call | Thu, May 16, 2024 · 10:00 AM ET | Replay |
All 18 calls
| Call | When | Status |
|---|---|---|
| Rubicon Organics (TSXV:ROMJ) Q3 2023 Earnings Call | Wed, Nov 15, 2023 · 10:00 AM ET | Replay |
| Rubicon Organics (TSXV:ROMJ) Q2 2023 Earnings Call | Thu, Aug 17, 2023 · 10:00 AM ET | Replay |
| Rubicon Organics (TSXV:ROMJ) Q1 2023 Earnings Call | Tue, May 23, 2023 · 10:00 AM ET | Replay |
| Rubicon Organics (TSXV:ROMJ) Q4 2022 Earnings Call | Mon, Apr 03, 2023 · 10:00 AM ET | Replay |
| Rubicon Organics (TSXV:ROMJ) Q2 2022 Earnings Call | Mon, Aug 15, 2022 · 10:00 AM ET | Replay |
| Rubicon Organics (TSXV:ROMJ) Q1 2022 Earnings Call | Tue, May 24, 2022 · 9:00 AM ET | Replay |
| Rubicon Organics (TSXV:ROMJ) Q4 2021 Earnings Call | Tue, Apr 19, 2022 · 10:00 AM ET | Replay |
| Rubicon Organics (TSXV:ROMJ) Q3 2021 Earnings Call | Wed, Nov 17, 2021 · 10:00 AM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Sep 30, 2026 | Nov 16, 2026 · Before open | −14.1% |
| Q2 2026 | Aug 11, 2026 · After close | +2.0% |
| Q1 2026 | May 13, 2026 · After close | −8.0% |
| Q3 2025 | Nov 12, 2025 · After close | +5.9% |
| Q1 2024 | May 15, 2024 · After close | −29.1% |
| Q4 2023 | Mar 26, 2024 · After close | −4.7% |
| Q1 2023 | May 23, 2023 · Before open | +2.0% |
| Q3 2022 | Nov 15, 2022 · Before open | +1.3% |
| Q2 2022 | Aug 12, 2022 · After close | +26.3% |
| Q1 2022 | Apr 18, 2022 · After close | −4.0% |
All 13 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q3 2021 | Nov 15, 2021 · After close | +2.8% |
| Quarter to Jun 30, 2021 | Aug 18, 2021 · After close | 0.0% |
| Quarter to Mar 31, 2021 | Apr 6, 2021 · Before open | +2.3% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (November 2026) | Investor deck | 17 slides | Nov 16, 2026 |
| Investor Presentation (October 2026) | Investor deck | 19 slides | Oct 19, 2026 |
| Investor Presentation (September 2026) | Investor deck | 20 slides | Sep 24, 2026 |
| Investor Presentation (June 2026) | Investor deck | 20 slides | Jun 17, 2026 |
| Investor Presentation (May 2026) | Investor deck | 19 slides | May 13, 2026 |
| Investor Presentation (March 2026) | Investor deck | 19 slides | Mar 23, 2026 |
| Investor Presentation (November 2025) | Investor deck | 21 slides | Nov 12, 2025 |
| Investor Presentation (October 2025) | Investor deck | 21 slides | Oct 15, 2025 |
| Investor Presentation (August 2025) | Investor deck | 21 slides | Aug 18, 2025 |
| Investor Presentation (August 2025) | Investor deck | 19 slides | August 2025 |
All 35 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Shareholder Meeting (July 2025) | Shareholder meeting | 25 slides | Jul 31, 2025 |
| Investor Presentation (May 2025) | Investor deck | 22 slides | May 28, 2025 |
| Investor Presentation (April 2025) | Investor deck | 23 slides | April 2025 |
| Investor Presentation (March 2025) | Investor deck | 21 slides | Mar 1, 2025 |
| Investor Presentation (March 2025) | Investor deck | 22 slides | Mar 1, 2025 |
| Investor Presentation (November 2024) | Investor deck | 33 slides | November 2024 |
| Investor Presentation (August 2024) | Investor deck | 33 slides | Aug 12, 2024 |
| Shareholder Meeting (July 2024) | Shareholder meeting | 37 slides | Jul 31, 2024 |
| Investor Presentation (July 2024) | Investor deck | 32 slides | July 2024 |
| Investor Presentation (May 2024) | Investor deck | 34 slides | May 16, 2024 |
| Investor Presentation (March 2024) | Investor deck | 33 slides | Mar 27, 2024 |
| Investor Presentation (February 2024) | Investor deck | 29 slides | February 2024 |
| Investor Presentation (February 2024) | Investor deck | 29 slides | February 2024 |
| Investor Presentation (December 2023) | Investor deck | 28 slides | Dec 4, 2023 |
| Investor Presentation (August 2023) | Investor deck | 25 slides | August 2023 |
| Investor Presentation (May 2023) | Investor deck | 18 slides | May 2023 |
| Investor Presentation (February 2023) | Investor deck | 16 slides | February 2023 |
| Investor Presentation (January 2023) | Investor deck | 17 slides | January 2023 |
| Shareholder Meeting (December 2022) | Shareholder meeting | 22 slides | Dec 13, 2022 |
| Investor Presentation (November 2022) | Investor deck | 14 slides | November 2022 |
| Investor Presentation (August 2022) | Investor deck | 26 slides | August 2022 |
| Shareholder Meeting (September 2021) | Shareholder meeting | 11 slides | Sep 15, 2021 |
| Investor Presentation (May 2021) | Investor deck | 27 slides | May 2021 |
| Investor Presentation (January 2021) | Investor deck | 24 slides | January 2021 |
| Fact Sheet (March 2019) | Fact sheet | 6 slides | March 2019 |
Financings
| Raise | Date | In US dollars |
|---|---|---|
| Private placement of common shares Closed: C$3M raised · C$0.45 a share Buyers: Siwash Rock Investments, Inc. (6,666,667 common shares at $0.45 per Share for approximately $3.0 million) Use of proceeds: Upgrade cultivation lighting and related greenhouse infrastructure at the Pacifica facility; balance to general working capital | Oct 19, 2026 | US$2.12M |
| Private placement of units Closed: C$4.5M raised · C$0.44 a unit · ½ warrant at C$0.7 for 24 months Buyers: Jesse McConnell (After the Offering, owns or controls 12,745,118 Common Shares (approximately 18.65% undiluted), 325,000 Options, 450,000 RSUs, 140,459 DSUs and 250,000 Warrants) Insiders: All members of the Board subscribed for an aggregate of 3,410,545 Units, gross proceeds of approximately $1,500,639 Use of proceeds: Start-up and acquisition costs of the Hope, B.C. facility, pre-roll automation and other capital investments, and general working capital | May 7, 2025 | US$3.26M |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in CAD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 59.5M | 48.7M | 40.1M | 35.5M | 22.6M | 9.39M | 454.0K | 2.03M | 884.4K | |
| Cost of revenue | 37.3M | 33.3M | 27.0M | 21.7M | 21.1M | 10.1M | -1.05M | 2.08M | 1.18M | |
| Gross profit | 22.1M | 15.4M | 13.1M | 13.8M | 1.51M | -664.0K | 1.05M | -52.4K | -300.4K | |
| Selling, general and administrative | 20.1M | 16.4M | 13.9M | 16.1M | 14.6M | 12.1M | 10.6M | 12.4M | 5.18M | |
| Operating income | 1.82M | -1.17M | -1.08M | -2.59M | -13.3M | -12.0M | -9.63M | -12.6M | -5.61M | |
| Depreciation and amortization | 3.36M | 3.27M | 3.12M | 3.05M | 2.40M | 1.72M | 1.62M | 258.4K | 175.6K | 175.6K |
| EBITDA | 5.18M | 2.10M | 2.04M | 461.4K | -10.9M | -10.3M | -8.01M | -12.4M | -5.43M | |
| Interest expense | 707.0K | 1.15M | 1.10M | 1.02M | 1.26M | 2.26M | 1.51M | 135.1K | 0 | 0 |
| Income before tax | 1.05M | -2.56M | -1.82M | -3.86M | -14.5M | -14.3M | -11.2M | -29.9M | -5.77M | |
| Income tax | -74.3K | 76.9K | ||||||||
| Net income | 1.05M | -2.56M | -1.82M | -3.86M | -14.5M | -15.0M | -14.3M | -29.9M | -5.85M | |
| Earnings per share, basic | 0.02 | -0.05 | -0.03 | -0.07 | -0.26 | -0.30 | -0.36 | -0.81 | -0.16 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 3.99M | 9.86M | 9.78M | 8.29M | 11.6M | 12.1M | 2.08M | 232.4K | 2.92M | 3.63M |
| Receivables | 9.05M | 5.62M | 3.32M | 4.77M | 4.14M | 2.15M | 204.9K | 490.6K | 37.9K | |
| Inventory | 19.5M | 12.6M | 11.3M | 12.7M | 10.6M | 10.1M | 4.12M | 352.1K | 237.4K | 666.3K |
| Current assets | 35.8M | 30.7M | 27.0M | 27.7M | 27.2M | 26.2M | 18.4M | 2.29M | 3.28M | 1.17M |
| Property, plant and equipment | 25.3M | 22.5M | 19.5M | 24.0M | 16.3M | |||||
| Total assets | 66.9M | 56.6M | 54.9M | 56.1M | 54.8M | 51.1M | 39.8M | 28.3M | 21.9M | 13.1M |
| Accounts payable | 1.52M | 1.78M | 1.15M | 681.2K | 1.57M | 1.75M | 2.56M | 2.02M | 1.62M | 124 |
| Current liabilities | 12.2M | 10.7M | 16.9M | 8.37M | 6.94M | 22.0M | 12.9M | 3.36M | 2.28M | 124 |
| Long-term debt | 10.3M | 8.48M | 9.40M | 8.95M | 8.36M | 2.85M | 2.95M | |||
| Total liabilities | 22.8M | 19.2M | 17.0M | 17.8M | 15.9M | 22.2M | 21.3M | 6.27M | 5.23M | 1.02M |
| Shareholders' equity | 44.1M | 37.4M | 37.9M | 38.3M | 38.9M | 28.8M | 18.5M | 22.1M | 16.7M | 12.1M |
| Shares outstanding | 67.2M | 56.5M | 56.2M | 56.1M | 56.0M | 49.4M | 40.0M | 36.8M | 36.8M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -3.04M | 3.40M | 6.79M | 1.95M | -10.4M | -14.3M | -10.1M | -9.30M | -4.20M | 5.95K |
| Capital spending | -8.42M | -1.55M | -3.38M | -4.45M | -5.50M | -5.98M | -7.94M | -9.10M | -4.88M | -4.88M |
| Free cash flow | -11.5M | 1.85M | 3.41M | -2.50M | -15.9M | -20.3M | -18.6M | -18.4M | -9.07M | -4.87M |
| Cash from investing | -5.50M | 3.08M | -5.34M | -9.08M | -9.02M | -1.53M | ||||
| Cash from financing | 5.67M | -1.77M | -829.3K | -838.6K | 15.3M | 21.3M | 17.2M | 15.5M | 12.8M | 2.68M |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Change in cash | -5.87M | 73.1K | 2.56M | -3.29M | -553.0K | 10.1M | 1.85M | -2.69M | -710.7K | 1.16M |
Filings
Cap table
Built by 6ix from Rubicon Organics, Inc.’s releases · as of Oct 19, 2026
- Common shares
- 74,245,583
- Fully diluted
- 80,046,001
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 74,245,583 | Oct 19, 2026 |
| Warrants | 5,113,632 | May 6, 2025 |
| Options and RSUs | 686,786 | Sep 24, 2026 |
Warrants and options
| Lot |
|---|
| Warrants · C$0.70 · expire about May 2027 |
| PSUs · expiry not stated |
Share count over time
| Count | Shares |
|---|---|
| Oct 19, 2026 | 74,245,583 |
| Jun 30, 2026 | 67,578,916 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Glen Ibbott Other companies: Aurora Cannabis Inc. (CFO · Nov 13, 2025 – Nov 5, 2026 · Past) | Chief Financial Officer · Since at least Nov 13, 2025 |
| Margaret Brodie Other companies: Aurora Cannabis Inc. (CEO · Nov 13, 2025 – Nov 5, 2026 · Past) | Chief Executive Officer · Since at least Nov 2, 2026 |
| Bob Hill | VP, Strategic Finance · Since at least Nov 4, 2026 |
| Doris Bitz | Chair · Since at least Jul 31, 2025 |
| Jesse McConnell | Director · Since at least Jul 31, 2025 |
| John Pigott | Independent Director · Since at least Jul 31, 2025 |
| Mathieu Aubin | VP, Marketing & New Business · Since at least Nov 18, 2025 |
| MediPharm Labs | Investor Relations · Jun 5, 2025 – Nov 4, 2026 · Past |
| Melanie Ramsey | Chief Operating Officer · Since at least Sep 16, 2026 |
| Michael Detlefsen | Independent Director · Since at least Jul 31, 2025 |
All 12 people
| Person | Seat |
|---|---|
| Monika Mascitti | VP, People & Culture · Since at least Nov 4, 2026 |
| Tyler Perkins | VP, Operations · Since at least Nov 4, 2026 |
Log in to ask 6ix AI your own questions about Rubicon Organics, Inc.